BioMelbourne News

Speaking Opportunities: Devices + Diagnostics Lab March 2018 – Disruptive Diagnostics

We’re starting to work on the Program for the 2018 Devices + Diagnostics Lab which will take place on Tuesday 27th March next year. If you have any suggestions for speakers, topics or technologies that you would like…

Ask Industry Anything (Again) – Tuesday 28th November 2017

BioMelbourne Network – Bringing industry and academia together! In November 2016, we launched “Ask Industry Anything” a new event which gave tables of students and researchers from leading academic organisations the opportunity to ask leaders from the biotechnology,…

BioMelbourne Network has appointed Lusia Guthrie to the BioMelbourne Network’s Board of Directors as of September 2017

With over 35 years in pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks. She started her career as a Medical Laboratory Scientist before joining the…

BioMelbourne Network Welcomes Revisions to Skilled Migration Visas

Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to the Medium…

2017 Connecting Women – Charity Announced!

The BioMelbourne Network Connecting Women Lunch is now fully booked with over 400 women set to attend on Friday 2nd June. We’re also delighted that we have received a record number of nominations for the BioMelbourne Network Women in Leadership…

Joint statement on the Research & Development Tax Incentive 18 April 2017

Don’t rip the guts out of Australian medical research commercialisation Commercialisation of Australian medical research is under serious threat if the package of measures put by the ‘Ferris, Finkel, Fraser’ Review of the Research & Development (R&D) Tax…

Launch of Global Health Alliance Melbourne

Global Health Alliance Melbourne (GLHAM) is an alliance for development and health equity in the Asia-Pacific, and is modelled on the highly successful Washington Global Health Alliance (link). The Alliance aims to optimise the collective capabilities of Melbourne-based…

Lusia Guthrie appointed to role of BioMelbourne Network Interim CEO

BioMelbourne Network is delighted to announce that after a thorough selection process, the Board has engaged Lusia Guthrie in the role of Interim CEO. Lusia will be responsible for the day to day management of the Association whilst Krystal…

27th March 2018 Devices + Diagnostics Lab – Disruptive Diagnostics

We’re pleased to announce that the theme for our annual Devices + Diagnostics Lab – one day symposium on Tuesday 27th March 2018 – will be “Disruptive Diagnostics”. The program will cover hot topics across the product development…

BioMelbourne Network and Medical Alley Enter Global Medical Technology Partnership

Minneapolis, Minnesota – BioMelbourne Network and Medical Alley have signed a memorandum of understanding (MoU) as a part of the Victorian Medtech Trade Mission to the US today. The trade mission is a collaborative initiative of the State…

BioMelbourne Network and MTPConnect sign MoU

Wednesday, 19 October 2016, Melbourne, Australia—BioMelbourne Network and MTPConnect have signed a memorandum of understanding (MoU), aligning Melbourne’s strengths with national priorities in the medical technology, biotechnology and pharmaceutical sector to boost Australia’s competitiveness, productivity and capacity in…

Melbourne Medtech arrives in Medical Alley for Advamed 2016

The Melbourne Medtech delegation has arrived in Medical Alley, Minneapolis for AdvaMed 2016 – the leading MedTech Conference in North America. It’s the 4th year that Melbourne has sent a delegation of companies to the conference, and the…

Home

News & opinion

Member Directory

Events